ORAMED PHARMACEUTICALS INC. — Balance Sheet Charts
26 snapshots of history · ending 2025-12-31 · SEC EDGAR
Source:10-K · 10-Q
Assets vs Liabilities
Cash Position Breakdown
Debt Structure
Working Capital Components
Capital Structure (LT Debt / Cash / Equity)
Total Assets↑+48.7% +$76M
$231M
Current Assets↓-6.9% -$10M
$133M
Cash & Equivalents↓-15.6% -$8M
$46M
ST Investments↑+57.4% +$2M
$5M
Receivables
—
Net PPE↓-16.0% -$112K
$586K
Total Liabilities
—
Current Liabilities↑+235.7% +$13M
$19M
Account Payables↓-43.9% -$346K
$443K
Long-Term Debt↑+298100.0% +$75M
$75M
Short-Term Debt
$32M
Stockholders Equity↑+36.6% +$53M
$200M
Retained Earnings↑+30.1% +$53M
$-123M
Operating Lease ROU Asset↑+81.2% +$336K
$750K
Operating Lease Liability↑+121.8% +$453K
$825K
Gross PP&E
—
Accumulated Depreciation
—
Total Debt Carrying Amount↑+298100.0% +$75M
$75M
Contract Liability↓-50.0% -$2M
$2M
Contract Liability (Current)
—
Contract Liability (Noncurrent)↓-50.0% -$2M
$2M
Remaining Performance Obligation
$2M